Tom Harkin:

“Our top researchers recognize that this new development does not mean that we should discontinue studying embryonic stem cells,” he said in a written statement. “Scientists may yet find that embryonic stem cells are more powerful. We need to continue to pursue all alternatives as we search for treatments for diabetes, Parkinson’s and spinal cord injuries.”